Joel Greenblatt Merck & Co., Inc. Transaction History

Gotham Asset Management, LLC

$6.49 Billion
Q1 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 176,908 shares of MRK stock, worth $23.5 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

176,908

Previous 144,208 22.68%

Holding current value

$23.5 Million

Previous $15.7 Million 48.48%

% of portfolio

0.36%

Previous 0.29%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $3.7 Million - $4.31 Million	32,700 Added 22.68%	176,908 $23.3 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $5.39 Million - $5.87 Million	53,836 Added 59.57%	144,208 $15.7 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $365,575 - $405,985	3,551 Added 4.09%	90,372 $9.3 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $9.19 Million - $10 Million	-84,621 Reduced 49.36%	86,821 $10 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $380,363 - $424,407	-3,695 Reduced 2.11%	171,442 $18.2 Million

Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $368,034 - $471,870	-4,209 Reduced 2.35%	175,137 $19.4 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $498,304 - $559,789	-5,895 Reduced 3.18%	179,346 $15.4 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $587,101 - $665,508	7,032 Added 3.95%	185,241 $16.9 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $5.03 Million - $5.63 Million	-68,360 Reduced 27.72%	178,209 $14.6 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $6.27 Million - $7.86 Million	86,773 Added 54.3%	246,569 $18.9 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $1.37 Million - $1.5 Million	19,085 Added 13.56%	159,796 $12 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $2.03 Million - $2.24 Million	-28,843 Reduced 17.01%	140,711 $10.9 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $3.92 Million - $4.62 Million	56,969 Added 50.6%	169,554 $13.1 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $3.83 Million - $4.25 Million	-53,321 Reduced 32.14%	112,585 $9.21 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $7.63 Million - $8.65 Million	-104,260 Reduced 38.59%	165,906 $13.8 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $2.05 Million - $2.34 Million	-29,155 Reduced 9.74%	270,166 $20.9 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $4.08 Million - $5.65 Million	-64,358 Reduced 17.7%	299,321 $23 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $19.5 Million - $22.1 Million	-251,954 Reduced 40.93%	363,679 $33.1 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $1.05 Million - $1.14 Million	13,788 Added 2.29%	615,633 $51.8 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $7.41 Million - $8.65 Million	106,071 Added 21.4%	601,845 $50.5 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $3.15 Million - $3.59 Million	45,283 Added 10.05%	495,774 $41.2 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $5.99 Million - $6.95 Million	91,861 Added 25.61%	450,491 $34.4 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $1.82 Million - $2.14 Million	-31,484 Reduced 8.07%	358,630 $25.4 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $17.9 Million - $21 Million	-352,359 Reduced 47.46%	390,114 $23.7 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $1.33 Million - $1.55 Million	26,165 Added 3.65%	742,473 $40.4 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $29 Million - $34.6 Million	561,991 Added 364.18%	716,308 $40.3 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $9.05 Million - $9.74 Million	154,317	154,317 $9.88 Million

Others Institutions Holding MRK

# of Institutions

3,765

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $337B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account